Pheast Therapeutics, Inc.

CIK 1943737 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pheast Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 16, 2025D0001231919-25-000321
Apr 10, 2025D/A0001943737-25-000001
Oct 28, 2022D0001943737-22-000002